Comparison of liver function status between home treated and hospital treated SARS-CoV-2 survivors

Authors

  • Mohammad Masum Alam Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Matiur Rahman Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
  • Indira Chowdhury Department of Biochemistry, Sheikh Hasina Medical College, Jamalpur, Bangladesh
  • Forhadul Hoque Mollah Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh

DOI:

https://doi.org/10.18203/2320-6012.ijrms20220270

Keywords:

SARS-CoV-2, Liver function status, ALT, Bilirubin

Abstract

Background: SARS-CoV-2 has emerged as one of the greatest challenges faced by the world. There is association of liver injury with SARS-CoV-2 infection indicated by abnormal ALT levels accompanied by altered bilirubin level in blood. The aim of the study was to evaluate the quantitative difference of serum ALT and bilirubin level in home and hospital treated patients.

Methods: A cross-sectional study was conducted in the Department of Biochemistry and Molecular Biology, Bangabandhu Sheikh Mujib Medical University, from July 2020 to June 2021. After infection most of the patients with mild symptoms were treated at home but patients with difficulty in breathing and various complications were treated at the hospital. Due to SARS-CoV-2 infection certain derangement of liver enzymes were noticed.

Results: This study was planned to evaluate the changes of liver enzymes (ALT) and serum bilirubin after the recovery of SARS-CoV-2 infected patients. The aim of the study was to compare the derangement of serum bilirubin and ALT in home and hospital treated patients.

Conclusions: There was no significant difference regarding liver function between these two groups.

References

Gupta R, Ghosh A, Singh AK, Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes & metabolic syndrome. 2020;14(3):211.

Omrani-Nava V, Maleki I, Ahmadi A, Moosazadeh M, Hedayatizadeh-Omran A, Roozbeh F, et al. Evaluation of hepatic enzymes changes and association with prognosis in COVID-19 patients. Hepatitis Monthly. 2020;20(4):1-10.

Saini RK, Saini N, Ram S, Soni SL, Suri V, Malhotra P, et al. COVID-19 associated variations in liver function parameters: a retrospective study. Postgraduate Medical Journal. 2022;98:91-7.

Anastasiou OE, Korth J, Herbstreit F, Witzke O, Lange CM. Mild versus severe liver injury in SARS-CoV-2 infection. Digestive Diseases. 2021;39(1):52-7.

Xu W, Huang C, Fei L, Li Q, Chen L. Dynamic Changes in Liver Function Tests and Their Correlation with Illness Severity and Mortality in Patients with COVID-19: A Retrospective Cohort Study. Clinical Interventions in Aging. 2021;16:675.

An YW, Song S, Li WX, Chen YX, Hu XP, Zhao J, et al. Liver function recovery of COVID-19 patients after discharge, a follow-up study. International journal of medical sciences. 2021;18(1):176.

Balderramo D, Mattos AZ, Mulqui V, Chiesa T, Plácido-Damián Z, Abarca J, et al. Abnormal Liver Tests during Hospitalization Predict Mortality in Patients with COVID-19: A Multicenter Study from South America. Canadian Journal of Gastroenterology and Hepatology. 2021; 2021.

Qian JD, Wang Y, Yao TT, Li HC. COVID-19-Related Abnormal Liver Enzymes Levels: A Retrospective Study; 2020.

Khurshid F, Iqbal S, Mumtaz M. Evaluation of liver function tests and C-reactive protein in COVID-19 (SARS Cov-2) positive patients diagnosed by Real-time PCR. MEDRIXIV; 2021.

Hayat A, Jaffar SR, Majeed N, Abbas S, Asghar J, Tayyab N. Association Of Liver Function Derangements With Disease Severity In Covid-19 Patients. PAFMJ. 2020;70(1):S280-4.

Singhai A, Pavan GS, Panda S. Evaluation of liver function in symptomatic COVID-19 patients. Journal of Family Medicine and Primary Care. 2021;10(9):3252.

Lenti MV, de Andreis FB, Pellegrino I, Klersy C, Merli S, Miceli E, et al. Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy. Internal and emergency medicine. 2020;15(8):1399-407.

Gan Q, Gong B, Sun M, Cao Z, Zheng Y, Zhang Y, et al. A high percentage of patients recovered from COVID-19 but discharged with abnormal liver function tests. Frontiers in physiology. 2021;12:314.

Vahidy FS, Pan AP, Ahnstedt H, Munshi Y, Choi HA, Tiruneh Y, et al. Sex differences in susceptibility, severity, and outcomes of coronavirus disease 2019: Cross-sectional analysis from a diverse US metropolitan area. PLOS ONE 2021;16(1):e0245556.

Gomez JM, Du-Fay-de-Lavallaz JM, Fugar S, Sarau A, Simmons JA, Clark B, et al. Sex Differences in COVID-19 Hospitalisation and Mortality. Journal of Women's Health 2021;30(5):646-53.

Downloads

Published

2022-01-29

How to Cite

Alam, M. M., Rahman, M., Chowdhury, I., & Mollah, F. H. (2022). Comparison of liver function status between home treated and hospital treated SARS-CoV-2 survivors. International Journal of Research in Medical Sciences, 10(2), 289–292. https://doi.org/10.18203/2320-6012.ijrms20220270

Issue

Section

Original Research Articles